646sek
7,1 %
Date:2025-07-30Time:12:32:11Latest report:Q1-2025List:First NorthTicker:CLS B
Market Cap:166 msekEnterprise Value:138 msekNet Sales:20,1 msekEarnings:-50,5 msekEmployees:0ISIN:SE0022049920

Ratios

10-year key figure history for Clinical Laserthermia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Clinical Laserthermia with index and moving average MA50 and MA200.

Stockprice:6,46
MA50:3,40
MA200:3,66
Price/MA200:76,5 %
RSI (14):74,1
Price/MA50:89,9 %

Description

Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.

Medical Equipment